While others have demonstrated a decrease in serum concentrations of ECP, IL5, IL8, and TNF-α with montelukast therapy in asthma, allergic rhinitis, and cystic fibrosis, we were unable to show any decrease of these in children with dyspepsia. Here, IL5 is linked to allergic rhinitis.